-- カナディアン・ナチュラル・リソーシズ（CNQ）は木曜日、第1四半期の調整後1株当たり利益が1.17カナダドル（0.86米ドル）となり、前年同期の1.16カナダドルから増加したと発表した。 ファクトセットが調査したアナリストは1.05カナダドルを予想していた。 3月31日締めの第1四半期の売上高は108億1000万カナダドルで、前年同期の109億4000万カナダドルから減少した。 ファクトセットが調査したアナリストは105億3000万カナダドルを予想していた。
Related Articles
Asia
Huluwa Pharmaceutical's Cough Granules Win Bid for Traditional Chinese Drug Procurement Program
Hainan Huluwa Pharmaceutical's (SHA:605199) pediatric lung heat cough granules won a bid for China's traditional drug procurement program, according to a Thursday filing with the Shanghai bourse.The granules help with lung function and help treat colds, bronchitis, and bronchopneumonia, among other conditions.
$SHA:605199
Asia
Nagase & Co's Profit Surges 30% in Fiscal Year 2025
Nagase & Co's (TYO:8012) profit attributable to owners of the parent jumped nearly 30% to 33.1 billion yen for the fiscal year 2025 from 25.5 billion yen a year earlier.The chemical manufacturer's basic earnings per share increased to 78.89 yen from 57.60 yen a year ago, according to a Tokyo bourse filing on Thursday.Net sales climbed 2.9% to 972.8 billion yen for the year ended March 31 from about 945 billion yen in the prior year.It declared a final dividend of 55 yen per share, payable from June 18.For the fiscal year 2026, the company expects attributable profit of 34.5 billion yen, EPS of 84.59 yen, and net sales of 1 trillion yen.Nagase plans to pay interim and year-end dividends of 13 yen and 14 yen per share, respectively, for the year, which is higher than the amount paid in the year-ago period.
$TYO:8012
Research
Vermilion Energy Target Eased To C$27 From $30, Keeps Outperform at National Bank, Notes "Consistent Well Performance Across Portfolio Underpins Momentum"
$VET.TO